Type 1 Diabetes is an autoimmune condition characterized by a deficiency in insulin due to the destruction of pancreatic β-cells. This leads to elevated blood glucose levels. The primary treatment involves daily administration of exogenous insulin, but it falls short in replicating natural insulin secretion of pancreatic β-cells, hindering effective glucose homeostasis. Optimal management of Type 1 Diabetes is achieved through insulin pumps and continuous glucose monitors. Unfortunately, the annual out-of-pocket expense for insulin can exceed $10,000, rendering it financially burdensome for individuals in a lower socioeconomic status who are dealing with Type 1 Diabetes. The objective of this poster presentation is to address the issues that people in low SES areas have when trying to obtain insulin for their T1DM and creating solutions for those issues.

Submitted as part of the BMS-515 Public Health and US Healthcare System course for MUCOM Research Day.

Creator

• Asghar, Shehr

Language

• English

Keyword

• Type 1 Diabetes

• autoimmune disorder

• pancreatic β-cells

• exogenous insulin

• socioeconomic status

Date created

• 2023

Resource type

• Poster

Rights statement

• http://rightsstatements.org/vocab/InC/1.0/